Age effect on vascular reactivity in Type1 diabetes

Diabetic Medicine

Volumn 28, Issue 7, 2011, Pages 833-837

  Grzelak, P ^a   Czupryniak, L ^b   Olszycki, M ^a   Majos, A ^a   Stefanczyk L ^a  

^a Radiology and Diagnostic Imaging Department   (Poland)

^b Medical University of Lodz ^*  (Poland)

Author keywords

Ageing; Type1 diabetes; Vascular reactivity; Vasodilation

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AGING; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ULTRASOUND; VASODILATATION;

ADOLESCENT; ADULT; AGING; BLOOD FLOW VELOCITY; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RISK FACTORS; YOUNG ADULT;

EID: 79958790077     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03277.x     Document Type: Article

References (24)

1. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
2. Anderson RA, Evans ML, Ellis GR, Graham J, Morris K, Jackson SK. The relationships between postprandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type2 diabetes. Atherosclerosis 2001; 154: 475-483.
3. Celemajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997; 30: 325-333.
4. Gokce N. Risk stratification of postoperative cardiovascular events via non-invasive assessment of endothelial function, a prospective study. Circulation 2002; 105: 1567-1572.
5. Cardillo C, Nambi SS, Kilcoyne C, Choucair WK, Katz A, Quon MJ. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100: 820-825.
6. Dogra G, Rich L, Stanton K, Watts GF. Endothelium-dependent and independent vasodilation studies at normoglycaemia in typeI diabetes mellitus with and without microalbuminuria. Diabetologia 2001; 44: 593-601.
7. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106: 640-642.
8. De Backer G. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601-1610.
9. Ramsey MW, Goodfellow J, Jones CJH, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995; 92: 3212-3219.
10. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol 2002; 39: 257-265.
11. Bots ML. Carotid intima thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 2002; 20: 2317-2325.
12. Hashimoto M, Miyamoto Y, Matsuda Y, Akita H. New methods to evaluate endothelial function: non-invasive method of evaluating endothelial function in humans. J Pharmacol Sci 2003; 93: 405-408.
13. Patel S, Celermajer DS. Assessment of vascular disease using arterial flow mediated dilatation. Pharm Reports 2006; 58: S3-S7.
14. Grzelak P, Marchwicka-Wasiak M, Czupryniak L, Zasadzińska G, Loba J, Stefańczyk L. Reakcja obwodowych naczyń te{ogonek}tniczych na bodziec nitratowy - ocena parametrów przepływu metoda{ogonek} kolorowej ultrasonografii dopplerowskiej (Colour Doppler ultrasound in assessing peripheral vessels reactivity to NO-donor administration stimulus). Diabetol Pol 2004; 11: 26-31.
15. Duffy SJ, Castle SF, Harper RW, Meredith IT. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation and flow-mediated dilation in human coronary circulation. Circulation 1999; 100: 1951-1957.
16. Healy B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol 1990; 16: 357-358.
17. Furchgott RF, Zawadzki D. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
18. Furchgott RF, Zawadzki D. The obligatory role of endothelial cells in the relaxation of acetylcholine in artherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-1051.
19. Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 2003; 108: 1064-1070.
20. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995; 74: 247-253.
21. Tsunekawa T, Hayashi T, Hatsuyo K, Daigo S, Hisako E, Akihisa I. Cerivastatin, a hydroxymethylglutaral coenzymeA reductase inhibitor, improves endothelial function in elderly diabetic patients within 3days. Circulation 2001; 104: 376-379.
22. Meeking DR, Cummings MH, Thornet S, Donald A, Clarkson P, Crook JR. Endothelial dysfunction in Type1 diabetic subjects with and without microalbuminuria. Diabet Med 1999; 16: 841-847.
23. Schalkwijk CG, Smulders RA, Lambert J, Donker AJM, Stehouwer CDA. ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type1 diabetic patients. Eur J Clin Invest 2000; 30: 853-860.
24. Arcaro G, Zenere BM, Saggiani F, Zenti MG, Monauni T, Lechi A. ACE inhibitors improve endothelial function in type1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care 1999; 22: 1536-1542.